Rosacea: Triggers, Treatment, and Long-Term Management
Rosacea is chronic, not curable — but highly manageable. The four subtypes, what triggers flares, and the most evidence-backed interventions.
Rosacea is a chronic inflammatory skin condition affecting roughly 1 in 10 adults, most commonly in people with lighter skin tones, though it occurs across all ethnicities. It is frequently misdiagnosed as acne or "sensitive skin." Understanding rosacea means understanding that there are four distinct subtypes, each with different presentations and treatments — and that the most common skincare advice (use more actives, exfoliate, try this serum) often makes rosacea worse.
The four subtypes
- Erythematotelangiectatic (ETR): persistent redness, visible blood vessels, flushing. Most common subtype.
- Papulopustular: red bumps and pustules that look like acne — but are not. Often misdiagnosed and treated with acne products, which worsen it.
- Phymatous: skin thickening, especially on the nose (rhinophyma). More common in men.
- Ocular: eye symptoms — dryness, burning, sensitivity to light. Often accompanies other subtypes.
- Common triggers: UV exposure, heat, alcohol, spicy food, hot drinks, stress, exercise, and some skincare ingredients (alcohol, fragrance, menthol, strong acids).
- Treatment: azelaic acid (15–20% prescription) and metronidazole (topical) for papulopustular. Brimonidine gel for persistent redness. IPL or laser for visible vessels. Isotretinoin for severe phymatous subtype.
- Skincare philosophy for rosacea: the fewer products the better. Fragrance-free, minimal ingredient lists, physical sunscreen only (mineral filters are less reactive).
Read next
Understanding Acne: Causes and What Helps
The four drivers of acne, which ingredients have real evidence, and the patience the process genuinely requires.
Read→Niacinamide: The Multitasker Worth Knowing
Why this form of vitamin B3 is one of the most versatile and well-tolerated ingredients in skincare — what it does, what it does not do, and how to use it.
Read→